Drug Profile

Gene writers - Tessera Therapeutics

Alternative Names: In vivo gene writing therapies-Tessera Therapeutics

Latest Information Update: 28 Oct 2024

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Tessera Therapeutics
Class Antineoplastics; Gene therapies; RNA
Mechanism of Action Alpha 1-antitrypsin expression modulators; Gene expression modulators; Phenylalanine hydroxylase expression modulators

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Preclinical Alpha 1-antitrypsin deficiency; Cancer; Hepatolenticular degeneration; Phenylketonuria

24 Oct 2024 Pharmacodynamics data from a preclinical studies in Alpha-1 antitrypsin deficiency released by Tessera therapeutics
20 Jun 2024 Pharmacodynamics data from a preclinical studies in Alpha-1 antitrypsin deficiency released by Tessera therapeutics
10 May 2024 Preclinical trials in Alpha 1-antitrypsin deficiency in USA (Parenteral) prior to May 2024

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com